Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Bullboard Posts
Comment by barmac6on Aug 19, 2011 10:31am
180 Views
Post# 18960151

RE: RE: RE: bid-ask

RE: RE: RE: bid-askRBC?

House Positions for HEM from 20110819 to 20110819

Ex House Bought $Value Ave Sold $Value Ave Net $Net
7 TD Sec 40,500 34,960 0.86 17,000 14,405 0.85 23,500 -20,555
2 RBC 11,000 9,390 0.85 3,000 2,610 0.87 8,000 -6,780
80 National Bank 5,000 4,350 0.87 0 5,000 -4,350
79 CIBC 5,000 4,200 0.84 500 420 0.84 4,500 -3,780
58 Qtrade 2,000 1,740 0.87 0 2,000 -1,740
89 Raymond James 500 420 0.84 0 500 -420
33 Canaccord 500 435 0.87 0 500 -435
1 Anonymous 3,000 2,550 0.85 3,000 2,610 0.87 0 60
9 BMO Nesbitt 4,500 3,915 0.87 5,000 4,300 0.86 -500 385
99 Jitney 3,000 2,550 0.85 5,000 4,335 0.87 -2,000 1,785
6 Union 0 3,500 3,010 0.86 -3,500 3,010
46 Macquarie 0 5,000 4,250 0.85 -5,000 4,250
85 Scotia 0 5,500 4,785 0.87 -5,500 4,785
14 ITG 0 8,000 6,810 0.85 -8,000 6,810
19 Desjardins 500 425 0.85 20,000 17,400 0.87 -19,500 16,975
Total 75,500 64,935 0.86 75,500 64,935 0.86 0 0
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse